Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for Nano-X Imaging in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn expects that the company will post earnings of ($0.61) per share for the year. Cantor Fitzgerald has a "Overweight" rating and a $12.00 price objective on the stock. The consensus estimate for Nano-X Imaging's current full-year earnings is ($0.92) per share.
Separately, D. Boral Capital assumed coverage on shares of Nano-X Imaging in a research note on Monday, January 6th. They set a "buy" rating and a $23.00 target price for the company.
Read Our Latest Analysis on NNOX
Nano-X Imaging Trading Down 5.8 %
Shares of NNOX stock traded down $0.51 on Thursday, reaching $8.24. 2,732,064 shares of the company's stock were exchanged, compared to its average volume of 4,718,643. The company's fifty day simple moving average is $7.37 and its 200 day simple moving average is $6.95. Nano-X Imaging has a 52 week low of $5.26 and a 52 week high of $14.28. The stock has a market capitalization of $476.11 million, a PE ratio of -9.69 and a beta of 1.97.
Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last issued its quarterly earnings results on Thursday, November 21st. The company reported ($0.23) EPS for the quarter. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. During the same quarter in the prior year, the company earned ($0.37) EPS.
Hedge Funds Weigh In On Nano-X Imaging
Several institutional investors have recently made changes to their positions in the company. Farther Finance Advisors LLC purchased a new position in Nano-X Imaging during the 3rd quarter valued at about $25,000. Gainplan LLC bought a new position in Nano-X Imaging in the fourth quarter worth approximately $92,000. Verition Fund Management LLC bought a new stake in Nano-X Imaging during the 3rd quarter valued at $88,000. Creative Planning purchased a new position in shares of Nano-X Imaging in the 3rd quarter valued at $107,000. Finally, The Manufacturers Life Insurance Company raised its position in shares of Nano-X Imaging by 14.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,210 shares of the company's stock worth $148,000 after acquiring an additional 2,600 shares in the last quarter. Hedge funds and other institutional investors own 21.49% of the company's stock.
Nano-X Imaging Company Profile
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Recommended Stories
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.